MorphoSys AG Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACLX
|
Arcellx, Inc. | $83.52 | $2.72 B | -49.3 | 130 | $110.32 M |
 CCCC
|
C4 Therapeutics, Inc. | $5.70 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $16.73 | $1.29 B | -7.16 | 85 | $0 |
 DICE
|
DICE Therapeutics, Inc. | $47.55 | $2.27 B | -21.91 | 71 | $0 |
 ELVN
|
Enliven Therapeutics, Inc. | $25.54 | $984.95 M | -11.97 | 52 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $26.69 | $1.65 B | -11.47 | 97 | $0 |
 GBIO
|
Generation Bio Co. | $2.46 | $216.88 M | -1.28 | 174 | $5.90 M |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.29 | $243.38 M | -1.59 | 129 | $0 |
 GOSS
|
Gossamer Bio, Inc. | $0.98 | $124.06 M | -0.65 | 135 | $0 |
 IMCR
|
Immunocore Holdings plc | $31.21 | $2.08 B | -26.72 | 497 | $249.43 M |
 IMRX
|
Immuneering Corporation | $2.51 | $40.63 M | -0.74 | 66 | $0 |
 IPSC
|
Century Therapeutics, Inc. | $1.71 | $244.54 M | -1.32 | 152 | $2.24 M |
 KRON
|
Kronos Bio, Inc. | $1.00 | $44.62 M | -0.37 | 58 | $6.29 M |
 LYRA
|
Lyra Therapeutics, Inc. | $0.26 | $19.53 M | -0.27 | 88 | $1.56 M |
 MLYS
|
Mineralys Therapeutics, Inc. | $12.09 | $652.38 M | -6.03 | 28 | $0 |
 MRSN
|
Mersana Therapeutics, Inc. | $1.89 | $261.85 M | -1.91 | 123 | $36.86 M |
 NVCT
|
Nuvectis Pharma, Inc. | $6.23 | $116.38 M | -4.5 | 13 | $0 |
 PCVX
|
Vaxcyte, Inc. | $114.24 | $7.72 B | -16.54 | 254 | $0 |
 PMVP
|
PMV Pharmaceuticals, Inc. | $1.49 | $85.40 M | -1.26 | 63 | $0 |
 REPL
|
Replimune Group, Inc. | $10.95 | $485.18 M | -2.44 | 331 | $0 |
 RLYB
|
Rallybio Corporation | $1.16 | $61.34 M | -0.79 | 25 | $0 |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 VTYX
|
Ventyx Biosciences, Inc. | $2.19 | $229.83 M | -1.01 | 73 | $0 |